Envoy Medical (COCH) Depreciation & Amortization (CF) (2022 - 2026)

Envoy Medical has disclosed Depreciation & Amortization (CF) across 5 years of filings, most recently posting $73000.0 for Q1 2026.

• Depreciation & Amortization (CF) for Q1 2026 came in at $73000.0, up 19.67% year-over-year; the trailing twelve-month figure through Mar 2026 was $329000.0 (up 27.52% YoY), and the FY2025 annual result was $302000.0, up 74.57% from the prior year.
• Depreciation & Amortization (CF) came in at $73000.0 for Q1 2026 at Envoy Medical, down from $80000.0 in the prior quarter.
• In the past five years, Depreciation & Amortization (CF) ranged from a high of $100000.0 in Q2 2024 to a low of $15000.0 in Q4 2023.
• The 5-year median for Depreciation & Amortization (CF) is $48500.0 (2024), against an average of $53357.1.
• Across the five-year window, Depreciation & Amortization (CF) tumbled 42.31% in 2023 and soared 244.83% in 2024, its largest moves.
• Envoy Medical's Depreciation & Amortization (CF) stood at $26000.0 in 2022, then sank by 42.31% to $15000.0 in 2023, then surged by 220.0% to $48000.0 in 2024, then jumped by 66.67% to $80000.0 in 2025, then slipped by 8.75% to $73000.0 in 2026.
• The last three Depreciation & Amortization (CF) figures came in at $73000.0 (Q1 2026), $80000.0 (Q4 2025), and $76000.0 (Q3 2025), per Business Quant data.